Ignite Creation Date:
2024-05-06 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02754011
Status:
COMPLETED
Last Update Posted:
2023-12-07
First Post:
2016-02-19
Brief Title:
Phase I Evaluating the Combination of RibociclibCapecitabine in Locally AdvancedMetastatic Breast Cancer HER2 Negative
Sponsor:
UNICANCER
Organization:
UNICANCER